page_banner

Products

1-Ethyl-2,3-dioxopiperazine CAS:59702-31-7

Short Description:

Catalog Number: XD96056
Cas: 59702-31-7
Molecular Formula: C6H10N2O2
Molecular Weight: 142.16
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD96056
Product Name 1-Ethyl-2,3-dioxopiperazine
CAS 59702-31-7
Molecular Formula C6H10N2O2
Molecular Weight 142.16
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

1-Ethyl-2,3-dioxopiperazine, also known as etoposide or VP-16, is a chemotherapeutic drug that is commonly used in the treatment of various types of cancer, including lung cancer, testicular cancer, and lymphomas. Etoposide belongs to a class of drugs known as topoisomerase inhibitors and its main mechanism of action involves blocking the activity of the enzyme topoisomerase II, which is essential for DNA replication and repair. Here, we will discuss the effects, applications, and potential side effects of 1-ethyl-2,3-dioxopiperazine.One of the primary effects of etoposide is its ability to prevent cancer cell growth and induce apoptosis, or programmed cell death. By inhibiting topoisomerase II, etoposide disrupts the normal functioning of DNA and prevents cancer cells from multiplying and spreading. This effect makes etoposide a crucial component of many chemotherapy regimens, as it helps to shrink tumors and control the progression of cancer.Etoposide is commonly used in combination with other chemotherapeutic agents to enhance its effectiveness. By combining etoposide with other drugs, synergistic effects can be achieved, leading to improved treatment outcomes. The specific combination and dosage of etoposide depend on the type and stage of cancer being treated, as well as individual patient factors.While etoposide is primarily used in the treatment of solid tumors, it has also shown efficacy in treating certain types of blood cancers, such as Hodgkin's lymphoma and non-Hodgkin's lymphoma. In these cases, etoposide is often combined with other chemotherapy drugs or used in combination with radiation therapy.As with any chemotherapy drug, there can be potential side effects associated with etoposide treatment. Common side effects include nausea, vomiting, hair loss, fatigue, and a decrease in blood cell counts. These side effects are typically temporary and reversible once treatment is completed. However, in some cases, more severe adverse effects can occur, such as allergic reactions, secondary cancers, or damage to the heart and lungs. It is important for patients to discuss these potential risks and benefits with their healthcare provider before starting etoposide treatment.In conclusion, 1-ethyl-2,3-dioxopiperazine, or etoposide, is a widely used chemotherapeutic drug that is effective in the treatment of various types of cancer. Its primary mechanism of action involves inhibiting topoisomerase II, leading to the prevention of cancer cell growth and induction of apoptosis. Etoposide is commonly used in combination with other drugs and has shown efficacy in treating solid tumors as well as certain blood cancers. While it can have side effects, careful monitoring and management can help minimize these effects and maximize the therapeutic benefits for patients.


  • Previous:
  • Next:

  • Close

    1-Ethyl-2,3-dioxopiperazine CAS:59702-31-7